BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Navidea Biopharmaceuticals 

425 Metro Place Northurt
Suite 400
Dublin  Ohio  43017  U.S.A.
Phone: 614-793-7500 Fax: 614 793 7520


SEARCH JOBS




Industry
Medical Device






 Company News
Navidea Biopharmaceuticals (NAVB) To Participate In The BTIG Emerging Technologies In Healthcare Diagnostics Investor Conference September 30th 9/30/2014 9:42:25 AM
Navidea Biopharmaceuticals (NAVB)’s Lymphoseek® Recommended By CHMP For European Approval In Sentinel Lymph Node Detection For Melanoma, Breast And Certain Head And Neck Cancers 9/26/2014 8:15:55 AM
Navidea Biopharmaceuticals (NAVB) Awarded $1.67M Fast Track National Institutes of Health (NIH) SBIR Grant For Evaluation Of Lymphoseekв In Cervical Cancer 9/23/2014 11:28:01 AM
Navidea Biopharmaceuticals (NAVB) Receives Orphan Drug Designation From FDA For Use Of Lymphoseek® In Head And Neck Cancers 9/19/2014 11:01:53 AM
Hainan Sinotau In-Licenses Radiopharmaceutical From Navidea Biopharmaceuticals (NAVB) Of The U.S. 9/5/2014 11:33:00 AM
Navidea Biopharmaceuticals (NAVB) Enters Lymphoseek® Development And Commercialization Agreement For China 9/4/2014 11:31:32 AM
Navidea Biopharmaceuticals (NAVB) Announces Second Quarter 2014 Financial Results; Total Revenues Grow To $1.1 Million 8/6/2014 9:29:58 AM
Navidea Biopharmaceuticals (NAVB) To Announce Second Quarter 2014 Financial Results On August 6, 2014 7/29/2014 9:48:47 AM
Navidea Biopharmaceuticals (NAVB) Announces 2014 Annual Meeting Results 7/18/2014 10:11:05 AM
Navidea Biopharmaceuticals (NAVB) Joins Essex Woodland’s Rheumco To Develop Radiopharmaceuticals For Detection And Treatment Of Arthritic Diseases 7/16/2014 9:38:38 AM
12345678910...